Drug
Zilebesiran clinical trials
Also written ALN-AGT01.
Keep track of what changes. Save the zilebesiran studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses zilebesiran is read from its arms, and is right about nine times in ten.
Testing it · 5
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseRecruitingPhase 3Alnylam PharmaceuticalsNCT07181109Written as Zilebesiran
- A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate HypertensionCompletedPhase 1/2Alnylam PharmaceuticalsNCT06423352Written as Zilebesiran
- Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)CompletedPhase 2Alnylam PharmaceuticalsNCT06272487Written as Zilebesiran
- A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate HypertensionCompletedPhase 2Alnylam PharmaceuticalsNCT04936035Written as ALN-AGT01
- A Study to Evaluate ALN-AGT01 in Patients With HypertensionCompletedPhase 1Alnylam PharmaceuticalsNCT03934307Written as ALN-AGT01
Given in every arm · 2 — zilebesiran is usual care beside what is tested
- A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With ZilebesiranRecruitingPhase 2Alnylam PharmaceuticalsNCT07553442Written as Zilebesiran
- Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)CompletedPhase 2Alnylam PharmaceuticalsNCT05103332Written as Zilebesiran
Codes
What other systems call zilebesiran · ClinicalTrials.gg INT016411
- UNII (FDA) E422BH4BRKZILEBESIRANOne source FDA
- NCI Thesaurus C179136ZilebesiranOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | E422BH4BRK | ZILEBESIRAN | One source FDA |
| NCI Thesaurus | C179136 | Zilebesiran | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.